Epivir Hbv is a brand-name medication that contains lamivudine as its active ingredient. Lamivudine is an antiviral drug belonging to the nucleoside reverse-transcriptase inhibitor (NRTI) class. It is supplied as a 100 mg pill and is prescribed to treat chronic hepatitis B virus (HBV) infection. In Hong Kong, the product is regulated by the Department of Health and is available only with a prescription (Rx).
Lamivudine interferes with the replication of viral DNA. After oral ingestion, the pill is absorbed and converted inside cells to its active triphosphate form. This active metabolite competes with the natural nucleoside substrate for the viral enzyme reverse transcriptase. By incorporating into the growing viral DNA chain, lamivudine causes premature termination, thereby reducing the production of new virus particles. The drug’s antiviral effect begins within a few days of the first dose, reaches peak plasma concentrations in about 0.5-2 hours, and maintains activity with once-daily dosing because of its half-life of roughly 5-7 hours.
Approved Indication
Other Recognized Uses
Dosing adjustments for renal impairment, pediatric patients, or special clinical scenarios should be determined by a qualified healthcare provider.
This article provides educational information about Epivir Hbv and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Lamivudine is sometimes combined with other antivirals such as tenofovir to improve viral suppression. However, combination therapy should only be prescribed after a clinician evaluates potential benefits, resistance patterns, and renal function.
If multiple doses are missed, contact your prescriber promptly. They may advise restarting the regimen or adjusting the schedule to avoid a sudden increase in viral replication.
Lamivudine reduces HBV DNA levels, which can lead to lower viral load readings. Liver enzyme tests (ALT/AST) may also improve, but occasional fluctuations are possible and should be interpreted by a clinician.
When traveling, keep the medication in its original container, carry a copy of the prescription, and be prepared to show it at customs if asked. Maintain the tablets at stable temperature, avoiding excessive heat or humidity.
Legitimate Epivir Hbv tablets are uniformly round, film-coated, and imprinted with the brand name and dosage strength. If the appearance deviates significantly, consult a pharmacist before use.
Yes. Because lamivudine is cleared renally, patients receiving hemodialysis often require a reduced dose (e.g., 50 mg after each dialysis session). A healthcare professional should tailor the regimen.
Weight fluctuations are not a common side effect of lamivudine. Any unexpected weight loss or gain should be discussed with a clinician to rule out other causes.
Do not flush tablets down the toilet. Return unused medication to a pharmacy collection point or follow the Hong Kong environmental agency’s guidelines for safe disposal.
Both are effective antivirals, but tenofovir generally has a higher barrier to resistance and is often preferred as first-line therapy. Lamivudine may still be used in specific clinical scenarios, especially where cost or availability is a factor.
